Nanomedicine Market Forecast Estimation & Approach 2020-2026 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc.,…

The Global Nanomedicine Market report provides information by Top Players, Geography, End users, Applications, Competitor analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast.

Initially, the report provides a basic overview of the industry including definitions, classifications, applications, and industry chain structure. The Nanomedicine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

To Get Copy of Sample Report Kindly Connect with us https://www.affluencemarketreports.com/industry-analysis/request-sample/894345/

2020 Global Nanomedicine Market Report is a professional and in-depth research report on the worlds major regional market conditions of the Nanomedicine industry, focusing on the main regions and the main countries (United States, Europe, Japan and China).

Global Nanomedicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer.

The Top players are

Nanomedicine Market Report based on Product Type:

Nanomedicine Market Report based on Applications:

Get Extra Discount on Nanomedicine Market Report, If your Company is Listed in Above Key Players List @ https://www.affluencemarketreports.com/industry-analysis/request-discount/894345/

The report introduces Nanomedicine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis. Insightful predictions for the Nanomedicine market for the coming few years have also been included in the report.

The report focuses on global major leading Nanomedicine Market players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.

The Nanomedicine industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

ENQUIRE MORE ABOUT THIS REPORT @ https://www.affluencemarketreports.com/industry-analysis/request-inquiry/894345/

CHAPTERS COVERED IN THIS REPORT ARE AS FOLLOW:

Chapter 1: Nanomedicine Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Nanomedicine Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Nanomedicine.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Nanomedicine.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Nanomedicine by Regions (2014-2020).

Chapter 6: Nanomedicine Production, Consumption, Export and Import by Regions (2014-2020).

Chapter 7: Nanomedicine Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Nanomedicine.

Chapter 9: Nanomedicine Market Analysis and Forecast by Type and Application (2020-2026).

Chapter 10: Market Analysis and Forecast by Regions (2020-2026).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

For More Details on Impact of COVID-19 on Nanomedicine Market https://www.affluencemarketreports.com/industry-analysis/covid19-request/894345/

About Affluence:

Affluence Market Reports is the next generation of all your research needs with a strong grapple on the worldwide market for industries, organizations, and governments. Our aim is to deliver exemplary reports that meet the definite needs of clients, which offers an adequate business technique, planning, and competitive landscape for new and existing industries that will develop your business needs.

We provide a premium in-depth statistical approach, a 360-degree market view that includes detailed segmentation, key trends, strategic recommendations, growth figures, Cost Analysis, new progress, evolving technologies, and forecasts by authentic agencies.

For more Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number: U.S +1-(424) 256-1722

Email: [emailprotected]

Website: http://www.affluencemarketreports.com

More:

Nanomedicine Market Forecast Estimation & Approach 2020-2026 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc.,...

IKBFU Scientists Develop a Plant-Based Technology for Obtaining Magnetic Nanoparticles with Antifungal Properties – QS WOW News

A team of researchers from obtained magnetic nanoparticles using a sweet flag (Acorus calamus). Both the roots and the leaves of this plant have antioxidant, antimicrobial, and insecticide properties. The extract of the sweet flag was used as a non-toxic reagent for the manufacture of coated particles.

The authors of the work also showed the efficiency of the new nanoparticles against several types of pathogenic fungi that damage cultivated plants. A technology developed by the team provides for the manufacture of nanoparticles from a cheap plant-based raw material and reduces the harmful effect of reagents on the environment. The results of the study were publishedin theNano-Structures & Nano-Objectsjournal.

Because of their unique properties, nanoparticles are used in many areas, from medicine to oil production. Their characteristics depend to a great extent on their size and shape, and the ratio between their surface area and volume plays a key role. The bigger it is, the stronger is a nanoparticles local effect.

Magnetic nanoparticles that can be controlled with an external magnetic field or emit heat under the influence of electromagnetic radiation have potential in biology and medicine. For example, particles with increased magnetic moment are used both in medical diagnostics and for the treatment of various conditions. Some studies also indicate that magnetic nanoparticles can have antifungal properties. For these applications, scientists suggest using barium ferrite nanoparticles in the biocompatible coating.

There are several methods of manufacturing coated nanoparticles with given characteristics, but all of them include toxic reagents. We have developed an environmentally friendly technology for the production of barium ferrite with the use of sweet flag extract. The surface of these particles has additional biological properties and the particles themselves possess all necessary magnetic and geometrical characteristics, said Prof. Larissa Panina, a Ph.D. in Physics and Mathematics from BFU.

The team mixed an extract made from dried sweet flag roots with barium and iron salts and water. Then, the mixture was heated to evaporate the liquid and obtain powder. After that, the powder was sintered at temperatures up to 900C, and nanoparticles were formed.

To study their morphology, the team used scanning electron microscopy. This method is based on scanning the surface of a studied object with an electron beam and applies to fragments that are just several nanometers in size. The average size of the hexagon-shaped nanoparticles was from 20 to 50 nm. The team also studied the crystalline structure and elemental composition of the particles using X-ray structural analysis and energy dispersive spectroscopy and found out that the new particles had no admixtures.

The barium ferrite nanoparticles synthesized by the team were active against four species of fungi that cause various diseases of fruit and flowering plants. Even in small concentrations, the nanoparticles were able to slow down the growth of pathogens. In the course of the Fenton reaction, the ions of iron in barium ferrite reacted with peroxides and reactive oxygen forms (OH radicals) appeared.

Being extremely active, they reacted with substances in harmful cell walls, damaged them, and thus slowed down the growth of pathogens. According to the authors of the study, this is a universal mechanism that might make the nanoparticles active against other species of fungi, too.

Read the rest here:

IKBFU Scientists Develop a Plant-Based Technology for Obtaining Magnetic Nanoparticles with Antifungal Properties - QS WOW News

Antibacterial Nanorobots Market Improvement, Orientation and Forecast from 2020-2026| Bruker, JEOL, Thermo Fisher – Farming Sector

LOS ANGELES, United States: The report titled, Global Antibacterial Nanorobots Cartons Market Report, History and Forecast 2015-2026 has been recently published by QY Research. The authors of the report have done extensive study of the global Antibacterial Nanorobots Cartons market keeping in mind the key aspects such as growth determinants, opportunities, challenges, restraints, and market developments. This analysis will enrich the ability of the companies involved in the global Antibacterial Nanorobots Cartons market to make precise decisions. The report also emphasizes on the current and future trends in the global Antibacterial Nanorobots Cartons market, which may bode well for the global Antibacterial Nanorobots Cartons market in the coming years. Impact of the driving factors on the global Antibacterial Nanorobots Cartons market growth has been mapped by the report. Besides, factors that are likely to challenge the global Antibacterial Nanorobots Cartons market growth in the years to come are discussed by the industry experts in the report.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/2217972/global-antibacterial-nanorobots-sales-market

The report thoroughly reviews the manufacturers operating in the global Antibacterial Nanorobots Cartons market. It offers figures pertaining to revenue, productions, and market share to provide a 360-degree view of it. They have used SWOT analysis to assess internal strengths, weaknesses, external opportunities, and threats. This is expected to help readers understand finer nuances of the market. This research report is presented in such a way that it helps a reader comprehend the market in wider aspects. In order to fulfil that goal, the researchers have divided the report into various chapters. It will provide readers with accurate and exact information, necessary for complete understanding of the market.

Key Players Mentioned in the Global Antibacterial Nanorobots Market Research Report: Bruker, JEOL, Thermo Fisher, Ginkgo Bioworks, Oxford Instruments, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Park Systems

Global Antibacterial Nanorobots Market by Type: 50-100 nm, > 100nm

Global Antibacterial Nanorobots Market by Application: Nanomedicine, Biomedical Science

The researchers have covered the various product type, end user, and application segments in the Global Antibacterial Nanorobots Cartons Market Report. They have studied the varieties of products available in the market. Assessment of investments and innovation in these products has also been mentioned in complete detail. The application segment also receives spotlight through evaluation of possible usages of products.

The regions covered in the Antibacterial Nanorobots Cartons Market Report includes Asia Pacific, South Asia, the Middle East and Africa, North America, South America, and Europe. The research report analyses all the factors augmenting each regional market. It provides the historic, current, and forecast figures for them. Changing government policies and political volatility have been discussed at great length in this chapter to offer clarity.

Questions Answered by the Report:

Which are the dominant players of the global Antibacterial Nanorobots market?What will be the size of the global Antibacterial Nanorobots market in the coming years?Which segment will lead the global Antibacterial Nanorobots market?How will the market development trends change in the next five years?What is the nature of the competitive landscape of the global Antibacterial Nanorobots market?What are the go-to strategies adopted in the global Antibacterial Nanorobots market?

Request for customization in Report: https://www.qyresearch.com/customize-request/form/2217972/global-antibacterial-nanorobots-sales-market

Table of Contents

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

Follow this link:

Antibacterial Nanorobots Market Improvement, Orientation and Forecast from 2020-2026| Bruker, JEOL, Thermo Fisher - Farming Sector

These Nature-Inspired Solutions Could Be The Key To A More Sustainable Future – Tatler Philippines

By Relaxnews December 28, 2020

Climate change and biodiversity loss are laying bare our dependence on the natural world for everything from the food we eat to the air we breathe.

Sign up for our newsletters to get all our top stories delivered.

You've Successfully Subscribed

Climate change and biodiversity loss are laying bare our dependence on the natural world for everything from the food we eat to the air we breathe.

But nature also holds the solution to other problems, inspiring scientific discovery in a host of unexpected ways.

Nature is "a source of inspiration for science, because it has figured out the way Earth supports life," said Lex Amore from the Biomimicry Institute.

"It is imperative we look to the biological blueprints that have been successful over millennia to launch groundbreaking ideas faster."

From smelly durian fruit that could charge electric cars to sea sponges that might help build better spaceships, here is a selection of this year's scientific work inspired by nature.

Read also: What Is "Ecocide" And Should It Be A Crime?

Removing tumours and blood clots through minimal invasive surgery may soon become easier thanks to a flexible, ultra-thin and steerable needle inspired by parasitic wasps.

These formidable insects inject their eggs into living hosts such as caterpillars through a hollow needle called the ovipositor.

Scientists from the Delft University of Technology in the Netherlands studied the ovipositor's delivery mechanism, with blades that slide up and down alternately, using friction to push the eggs through.

Researchers designed a needle made up of sliding rods that imitate the ovipositor, according to a recent study in Frontiers in Bioengineering and Biotechnology.

They say the new needle is capable of reaching deeply buried parts of the body to inject medicine or remove harmful formations, while minimising trauma and patient recovery time.

This is a starkly different outcome than for the targets of parasitic wasps, whose larva often devour their caterpillar host from the inside.

Spiders make silk to entangle unsuspecting bugs, but now humans can use it to make optical lenses capable of picturing viruses that are invisible to the naked eye.

In a June study published in the Journal of Applied Physics, scientists said they used daddy-long-legs' dragline silk -- which makes a web's frame -- as a support for the lens.

In experiments, they covered a strand of spider silk in wax then dripped resin onto it. As it condensed, the silk naturally formed a dome, which researchers baked in an ultraviolet oven.

The resulting optical lens is about the size of a red blood cell and could be used to picture nano-scale objects like viruses or the insides of biological tissue.

As the lens is made from natural, non-toxic material, it can safely be used inside the body.

Read also: 3 Ways To Make Your Home Environmentally Sustainable

An intricately latticed marine sponge called the Venus' flower basket found in the depths of the Pacific Ocean could inspire stronger skyscrapers, longer bridges and lighter spacecraft, according to a September study published in Nature Materials.

Scientists discovered that the structure of the sponge's tubular skeleton gives it a higher strength-to-weight ratio than traditional designs that have been used for centuries for buildings and bridges.

"We've been studying structure-function relationships in sponge skeletal systems for more than 20 years, and these species continue to surprise us," said co-author James Weaver, a Harvard University scientist.

To some they are succulent and delicious, to others they are so overpoweringly stinky that they are routinely banned from hotel rooms across Southeast Asia.

But the durian fruit may be about to add a new unexpected reason for its fame -- helping to charge mobile phones and electric cars.

In a February study published in the Journal of Energy Storage, scientists described how they made extremely light and porous materials called aerogels from the fruit.

Aerogels are "great super-capacitors", which resemble energy reservoirs that dole out energy smoothly, said co-author and Sydney University associate professor Vincent Gomes.

"(Super-capacitors) can quickly store large amounts of energy within a small battery-sized device," he said.

They can then supply energy to charge electronic devices such as mobile phones, tablets and laptops within a few seconds, he added.

Read also: World Wildlife Fund PH: The New Normal Must Become A Green One

Cars, aeroplanes and buildings are mostly made of steel, concrete or brick.

Bamboo has attracted interest as a versatile construction material. But how to make it strong enough? In a May study published in the ACS Nano, researchers said they had found an answer.

By partially removing the lignin -- an organic substance which forms woody tissue -- and microwaving the bamboo, researchers said its strength nearly doubled.

Bamboo is already used to build houses and bridges, but this new discovery may further increase its popularity as a light, fast-growing and sustainable alternative to polluting materials.

From forests to the depths of the oceans, Amore from the Biomimicry Institute said there was "so much intelligence" to tap into in the natural world.

"We can use biomimicry, this practice of studying nature and replicating its strategies in design, to not only learn from nature's wisdom, but also heal ourselves -- and this planet -- in the process."

Originally posted here:

These Nature-Inspired Solutions Could Be The Key To A More Sustainable Future - Tatler Philippines

Targeted nanomedicines for the treatment of bone disease and regeneration – DocWire News

This article was originally published here

Med Res Rev. 2020 Dec 21. doi: 10.1002/med.21759. Online ahead of print.

ABSTRACT

Targeted delivery by either passive or active targeting of therapeutics to the bone is an attractive treatment for various bone related diseases such as osteoporosis, osteosarcoma, multiple myeloma, and metastatic bone tumors. Engineering novel drug delivery carriers can increase therapeutic efficacy and minimize the risk of side effects. Developmnet of nanocarrier delivery systems is an interesting field of ongoing studies with opportunities to provide more effective therapies. In addition, preclinical nanomedicine research can open new opportunities for preclinical bone-targeted drug delivery; nevertheless, further research is needed to progress these therapies towards clinical applications. In the present review, the latest advancements in targeting moieties and nanocarrier drug delivery systems for the treatment of bone diseases are summarized. We also review the regeneration capability and effective delivery of nanomedicines for orthopedic applications.

PMID:33347711 | DOI:10.1002/med.21759

The rest is here:

Targeted nanomedicines for the treatment of bone disease and regeneration - DocWire News

US Virtual 3D Nanorobots Market 2020: Deep Analysis of Current Trends and Future Demand by Top Key Players are Gingko Bioworks, Synthace, Zymergen…

Virtual 3D Nanorobots Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025Increasing prevalence of chronic diseases and rising adoption of technologically advanced medical equipments drive the growth of global virtual 3D nanorobots Market.

Get Sample Copy of The Activated Alumina Market Report 2020@ https://brandessenceresearch.com/requestSample/PostId/555

*The sample pages of this report is immediately accessible on-demand.**

Scope of Global Virtual 3D Nanorobots Market Report-

Nanorobots are nano electromechanical systems designed to perform a specific task with precision at nano scale dimensions. It will be mainly used for the treatment in field of nanomedicine. An interesting utilization of nanorobots may be their attachment to transmigrating inflammatory cells or WBC, to reach inflamed tissues and assist in their healing process. It can also used for biomedical instrumentation, early diagnosis and targeted drug delivery for cancer, pharmacokinetics, surgery, monitoring of diabetes and health care. Virtual 3D nanorobots are expected to provide personalized treatments with improved efficacy and reduced side effects that are not available today. Virtual 3D nanorobots can be used to treat genetic diseases by comparing the molecular structures of both DNA and proteins found in the cell to known or desired reference structures. Some of its potential applications are; early diagnosis and targeted drug delivery for cancer biomedical instrumentation, pharmacokinetics, monitoring of diabetes, surgery and others. Another possible application can be the capability to locate atherosclerotic lesions in stenosed blood vessels, particularly in the coronary circulation, and treat them either mechanically, chemically or pharmacologically.

Virtual 3D nanorobots marketreport is segmented on the basis of type, application, distribution channel and region & country level. Based upon type, global virtual 3D nanorobots market is classified into microbivore nanorobots, respirocyte nanorobots, clottocyte nanorobots. Based upon application, global virtual 3D nanorobots market is divided into dentistry, emerging drug delivery, brain aneurysm, cancer detection, gene therapy, nanomedicine, biomedical, healthcare and others.

The regions covered in this Virtual 3D Nanorobots Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Virtual 3D Nanorobots is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Some major key players for Global Virtual 3D Nanorobots Market Gingko Bioworks, Synthace, Zymergen Inc., Advanced Diamond Technologies and Advanced Nano Products Co. Limited and others.

Increasing Prevalence of Chronic Diseases and Rising Adoption of Technologically Advanced Medical Equipments Drive the Growth of Global Virtual 3D Nanorobots Market

Nanorobots are expected to provide new treatments for the patients suffering from different diseases. Latest developments in the field of biomolecular computing have demonstrated the feasibility of processing logic tasks by bio-computers. The major factor driving the growth of global virtual 3D nanorobots market is increasing adoption of technologically advanced products in healthcare coupled with the rising government initiatives in this field. In addition, increasing prevalence of chronic diseases, improving healthcare infrastructure and technological advancements to develop more innovative, better and effective medical treatments are also anticipated to foster the market growth within the forecast period. In recent years, the potential of nanotechnology motivated many governments to devote significant resources to this new field. The U.S. National Science Foundation launched a program in Scientific Visualization in part to harness supercomputers in picturing the nanoworld. Firms such as; IBM, PARC, Hewlett Packard, Bell Laboratories, and Intel Corp. and others are collaborating to produce new nano products.

Cancer can be successfully treated with current stages of medical technologies and therapy tools. One of the important aspect to achieve a successful treatment for cancer patients is the development of efficient targeted drug delivery to decrease the side effects from chemotherapy. Nanorobots can help on such extremely important aspects of cancer therapy owing to the properties of nanorobots to navigate as blood borne devices. Nanorobots with embedded chemical biosensors can be used to perform detection of tumour cells in early stages of development inside the patients body. Thus all these advantages of nanorobots are expected to boost the market growth.

However, lack of trained professional may hamper the market growth. In spite of that, increasing advancements in the field can provide various opportunities for the further growth of the market. The use of nanorobots may advance biomedical intervention with minimally invasive surgeries and help patients who need constant body functions monitoring, or ever improve treatments efficiency through early diagnosis of possible serious diseases.

North America is Expected to Dominate the Global Virtual 3D Nanorobots Market

The global virtual 3D nanorobots market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global virtual 3D nanorobots market within the forecast period attributed to the highly developed healthcare infrastructure and increasing adoption of new technologies in healthcare in this region. In addition, increasing government initiative in this field are also supplementing the growth of virtual 3D nanorobots market in this region. Asia Pacific is anticipated to witness a significant growth in global Virtual 3D Nanorobots market owing to emerging economies and growing awareness about nanorobotics in healthcare. In addition, improving healthcare infrastructure due to the favourable government initiatives regarding health are also expected to foster the growth of virtual 3D nanorobots market in this region within the forecast period.

Key Benefits for Market Report

Virtual 3D Nanorobots MarketSegmentation:-

By Type: Respirocyte Nanorobots, Microbivore Nanorobots, Clottocyte Nanorobots

By Application:-Dentistry, Gene therapy, Brain Aneurysm, Emerging Drug Delivery, Cancer detection, NanoMedicine, Biomedical, Healthcare, Others

By Regional & Country Analysis

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Get Full Report :@ https://brandessenceresearch.com/technology-and-media/virtual-d-nanorobots-market

Related Links : https://sites.google.com/view/industrytrends/healthcare-industry-trends/contract-research-organization-market-size-will-grow-at-a-cagr-of-7-4

https://sites.google.com/view/industrytrends/ict-and-media/cyber-security-in-healthcare-market-2020-industry-analysis

https://sites.google.com/view/industrytrends/ict-and-media/data-monetization-market-key-vendors-growth-analysis-revenue-strategies

https://sites.google.com/view/industrytrends/semiconductor-and-electronics/electronic-shelf-label-esl-market-insights-forecasts-to-2025

https://sites.google.com/view/industrytrends/ict-and-media/endpoint-security-market-to-undertake-strapping-growth-by-the-end-2025

https://sites.google.com/view/industrytrends/healthcare-industry-trends/enteral-syringe-market-to-hit-usd-840-2-million-with-a-cagr-of-4-9-2025

https://sites.google.com/view/industrytrends/healthcare-industry-trends/epigenetics-market-size-to-reach-2-83-billion-by-2025

https://teletype.in/@shubhamgosavi/QXRihGbpR

https://teletype.in/@shubhamgosavi/0WtqR9ujr

https://teletype.in/@shubhamgosavi/3M6_tiypz

https://teletype.in/@shubhamgosavi/So4_UMfi2

https://teletype.in/@shubhamgosavi/QUPceMECm

https://teletype.in/@shubhamgosavi/-SkVcnYSW

https://teletype.in/@shubhamgosavi/h-MbmBF30i

https://teletype.in/@shubhamgosavi/UIsVVmi9Z

https://socialmarketingsubmisssion1.blogspot.com/2020/12/chemical-catalyst-market-expected-to.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/contract-research-organization-market.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/cyber-security-in-healthcare-market.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/data-monetization-market-key-vendors.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/electronic-shelf-label-market-size-2020.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/endpoint-security-market-to-undertake.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/enteral-syringe-market-to-hit-usd-8402.html

https://socialmarketingsubmisssion1.blogspot.com/2020/12/epigenetics-market-size-to-reach-283.html

About Us:

Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us atsales@industrystatsreport.com

Website:https://brandessenceresearch.com/

Article:https://businessstatsnews.com

Blog:http://www.dailyindustrywatch.com

Blog:https://marketsize.biz

Blog:https://technologyindustrynews.com

Blog:https://marketstatsreport.com

Excerpt from:

US Virtual 3D Nanorobots Market 2020: Deep Analysis of Current Trends and Future Demand by Top Key Players are Gingko Bioworks, Synthace, Zymergen...

Healthcare Nanotechnology (Nanomedicine) Market : Updates, Future Growth, Industry Analysis And Comprehensive Study On Key Players To 2020 2028 -…

Healthcare Nanotechnology (Nanomedicine) Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.

A 360 degree outline of the competitive scenario of the Global Healthcare Nanotechnology (Nanomedicine) Market is presented by Quince Market Insights. It has a massive data allied to the recent product and technological developments in the markets.

Sample Copy of This Report: https://www.quincemarketinsights.com/request-sample-64780?utm_source=biznews/ARSHAD

It has a wide-ranging analysis of the impact of these advancements on the markets future growth, wide-ranging analysis of these extensions on the markets future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Sanofi SA, Pfizer Inc., Celgene Corporation, Luminex Corporation, and Taiwan Liposome Company Ltd.

Reasons for buying this report:

By Application (Drug Delivery, Biomaterials, Active Implants, Diagnostic Imaging, Tissue Regeneration), By Disease (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases and Other Diseases)

Healthcare Nanotechnology (Nanomedicine)

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-64780?utm_source=biznews/ARSHAD

A detailed outline of the Global Healthcare Nanotechnology (Nanomedicine) Market includes a comprehensive analysis of different verticals of businesses. North America, Latin America, Asia-Pacific, Africa, and Europe have been considered for the studies on the basis of several terminologies.

This is anticipated to drive the Global Healthcare Nanotechnology (Nanomedicine) Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Healthcare Nanotechnology (Nanomedicine) Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Healthcare Nanotechnology (Nanomedicine) Market. The feasibility of the new report is also measured in this research report.

Table of Contents:

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 144 439 0986

Email: sales@quincemarketinsights.com

Web: https://www.quincemarketinsights.com

Follow this link:

Healthcare Nanotechnology (Nanomedicine) Market : Updates, Future Growth, Industry Analysis And Comprehensive Study On Key Players To 2020 2028 -...

Global Nanomedicine market 2020- Industry Overview, Global Trends, Market Analysis, CAGR Values and Country Level Demand To Forecast by 2027 -…

Global Nanomedicine market Industry Trends and Forecast to 2027 New Research Report Added to Databridgemarketresearch.com database. The report width Of pages : 350 Figures: 60 And Tables: 220 in it. To build an influential report, detailed market analysis has been conducted with the inputs from industry experts. By working on a number of steps for collecting and analysing market data, this supreme market research report is prepared with the expert team. It describes various definitions and segmentation or classifications of the industry, applications of the industry and value chain structure. Businesses can obtain a complete knowhow of general market conditions and tendencies with the information and data involved in the credible Global Nanomedicine market business report. The foremost areas of market analysis such as market definition, market segmentation, competitive analysis and research methodology are looked upon very vigilantly and precisely throughout the report.

Global nanomedicine market is registering a healthy CAGR of 15.50% in the forecast period of 2019-2026. This rise in the market value can be attributed to increasing number of applications and wide acceptance of the product globally. There is a significant rise in the number of researches done in this field which accelerate growth of nanomedicine market globally.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-market

Key Market Competitors

Few of the major market competitors currently working in the global nanomedicine market are Abbott, Invitae Corporation, General Electric Company, Leadiant Biosciences, Inc., Johnson & Johnson Services, Inc., Mallinckrodt, Merck Sharp & Dohme Corp., NanoSphere Health Sciences, Inc., Pfizer Inc., CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd., Gilead Sciences, Inc., Amgen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Luminex Corporation, Eli Lilly and Company, Nanobiotix, Sanofi, UCB S.A., Ablynx among others.

Competitive Landscape

Global nanomedicine market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nanomedicine market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

Market Drivers are Restraints

Grab Your Report at an Impressive 30% Discount! Please click Here @ https://www.databridgemarketresearch.com/request-a-discount/global-nanomedicine-market

Market Segmentation:-

By Product Type

By Application

By Indication

By Modality

To comprehend Global Nanomedicine market dynamics in the world mainly, the worldwide Nanomedicine market is analyzed across major global regions.

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-market

Nanomedicine Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Nanomedicine report provides the complete structure and fundamental overview of the industry market.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

View post:

Global Nanomedicine market 2020- Industry Overview, Global Trends, Market Analysis, CAGR Values and Country Level Demand To Forecast by 2027 -...

ACED one year on: a promising first year for the early detection research alliance – Cancer Research UK

The International Alliance for Cancer Early Detection (ACED) is a 55 million ($70 million) partnership between Cancer Research UK (CRUK) and five of the worlds foremost centres in early detection research. One year on, we look at four recently awarded research projects, which show how the Alliance is building a scientifically diverse and collaborative research community in the UK and the US, united at the forefront of cancer early detection.

Detecting and diagnosing cancer early is complex and has been hindered by scientific and clinical challenges. With a fragmented research community, limited access to early-stage tissue samples and a lack of commitment or prioritisation from industry and research funders, research progress in this emerging field has been slow.

Founded in 2019, ACED is a CRUK partnership with the Canary Center at Stanford University, the University of Cambridge, the Knight Cancer Institute at Oregon Health and Science University (OHSU), University College London and the University of Manchester. The Alliance brings together leaders in early detection research in a collaborative community, to work together to generate novel ideas and share knowledge. Its research strategy spans the scientific pipeline; from understanding the fundamental biology of early stage disease to developing new technological approaches and implementing early detection strategies through clinical trials and health systems.

The five ACED Member Centres can access funding in three areas: core funding for building capacity; shared infrastructure funding for training, networking and research platforms/resources; and joint funding for collaborative research activities. In its first year, 14 research projects have been funded including 3 Project Awards, 9 Pilot Awards and 2 Skills Exchange and Development Travel Awards.

Project Award, led by: Georgios Lyratzopoulos, University College London; Antonis Antoniou, University of Cambridge; and Ruth Etzioni, Oregon Health and Science University

Currently, about 90% of cancer patients in England are diagnosed after symptom onset. Appropriately assessing the risk of undiagnosed cancer in patients who present with new symptoms is therefore critical for achieving earlier diagnosis. Yet our approach to classifying such risk is imperfect. Clinical guidelines do not encompass lower-risk symptoms, which are the presenting features of about half of all patients. Further, among patients who do present with high-risk symptoms mandating urgent referrals, only one in 12 are found to have cancer. In 2019, the last pre-pandemic year, about 2 million patients in England who were investigated urgently were found not to have cancer, and improvements in risk classification could allow NHS diagnostic services to be used more efficiently in the future.

To improve upon these two problems, and drawing on their statistical, computational and health informatics expertise and that of their collaborators, Georgios, Antonis and Ruth will utilise rich electronic health record data to develop algorithms to risk-stratify patients presenting with symptomatic-but-as-yet-undiagnosed cancer. In particular, they will aim to incorporate information on the patients medical history (with regard to diagnostic investigations, morbidities and past medications) into their algorithm, together with information on underlying susceptibility to cancer due to lifestyle-related exposures or genetic risk.

Beyond improving the assessment of cancer risk, this project will also facilitate future early detection research by delivering reproducible operational definitions (otherwise known as patient record phenotypes), that can be used by other members of the Alliance and the scientific community at large when using novel patient record datasets in the UK, the US and globally.

Project Award, led by: Marc Tischkowitz, University of Cambridge; Allison Kurian, Canary Center at Stanford for Cancer Early Detection; and Gareth Evans, University of Manchester

CanRisk is a validated cancer risk assessment tool which combines genetic, lifestyle, clinical and imaging data to calculate an individual risk estimate for women with high-risk mutations in BRCA1 and BRCA2. Currently the women who carry these mutations are given wide cancer risk estimates. For example, someone might be told they have a 5085% lifetime risk of developing breast cancer. But for that individual, they really want to know is it nearer to 50% or 85%, or perhaps even outside that range?

Now, with an ACED Project Award, Allison, Gareth and Marc are collaborating to determine how CanRisk can be best used in the clinic. The researchers will recruit patients via genetics clinics in the UK and US, randomising them between a personalised or conventional risk estimate group. They will follow patient uptake of cancer surveillance and risk-reducing mastectomy, as well as analysing psychological and economic measures. The international nature of this project, across three centres in two different countries, will enable the team to investigate the difference in early detection uptake across different health systems. Moreover, it will benefit the wider research community by establishing a risk-stratified cohort that could form the basis for further early detection studies in the future.

Pilot Award, led by: Alice Fan, Canary Center at Stanford for Cancer Early Detection; Emma Woodward, University of Manchester; and Eamonn Maher University of Cambridge

Platelet transcriptomes have the ability to respond to the presence of different cancer types by splicing RNA into specific patterns. Rapid platelet turnover and the ability to propagate this transcriptional response throughout the entire platelet population may prove to be a very sensitive biomarker for cancer.

Alices lab at Stanford has generated promising preliminary data for a candidate platelet transcriptomic signature for early-stage renal cell cancer. With this ACED Pilot Award, Emma, Eamonn and Alice will join forces to investigate if this signature can be used to complement diagnostic imaging for the early diagnosis of kidney cancer in high-risk families with hereditary renal cell carcinoma syndromes.

Skills Exchange and Development Travel Award, Christian Hoerner, Canary Center at Stanford for Cancer Early Detection

Isolating platelets from fresh whole blood for transcriptome profiling can be very tricky. Platelets activate very easily and contain only tiny amounts of RNA, 10,000 times less than white blood cells. Christian, a researcher in Alices lab, has been awarded a Skills Exchange and Development Travel Award to share his platelet isolation protocol with the Manchester and Cambridge teams. This award directly addresses a key aim of the ACED Alliance to drive the exchange of knowledge between teams and minimise duplication.

COVID-19 has undoubtedly had a significant impact on the first year of the ACED Alliance, delaying the start of many projects when labs were forced to shut, and clinicians redeployed to respond to the virus.

Alliance members have rapidly had to adapt the way they come together to create new collaborations and ideas. Planned in-person networking events were quickly reimagined as virtual ones and members have held numerous online meet-and-greet events on topics including model systems, epidemiological approaches, non-invasive sampling, nanomedicine and career development for early career researchers. We know of at least two successful grant applications that were brokered at virtual events, as researchers continue to build connections across multiple disciplines and centres.

As the Alliance develops, there will be many opportunities to work with us, including:

If you're interested in working with us, we'd love to hear from you.

By David Crosby, Head of Prevention and Early Detection Research, Cancer Research UK

Sanjiv Sam Gambhir, MD, PhD, professor and chair ofradiologyat theStanford School of Medicineand an internationally recognised pioneer in molecular imaging, died of cancer on 18 June 2020.

Sam was a giant in the field of early detection of cancer, well known for the development of positron emission tomography reporter genes. His work was novel and wide-reaching, developing multiple other approaches to early detection of disease, including microbubbles and immunodiagnostics. Through his work as director of the Canary Center at Stanford for Cancer Early Detection, he was a passionate advocate of devising ambitious plans to deliver paradigm-changing opportunities for early detection and a champion of ACEDs mission. He was a critical founding member of the Alliance Executive Board.

It is certainly the case that ACED would not exist without Sam. He was the inspiration that led directly to the concept of ACED, and only through his ingenuity and positivity did that concept develop into the flourishing reality that ACED now is. We, and the world, are greatly diminished for his loss.

Sam was posthumously given the Don Listwin Award for outstanding contribution to the field of cancer early detection at this years Early Detection of Cancer Conference. Before his death, Sam was also awarded the Deans Medal, the University of Stanford School of Medicines highest honour, for his revolutionary contributions to biomedicine and to human health. To find out more about Sams life and his legacy watch the Deans Medal Tribute video.

See more here:

ACED one year on: a promising first year for the early detection research alliance - Cancer Research UK

Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies, 2020 Report – Focus on Latest Advancements for Chronic Pain…

DUBLIN--(BUSINESS WIRE)--The "Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies 2020" report has been added to ResearchAndMarkets.com's offering.

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations in digital health, microbiome, and flu vaccines technologies. The TOE also provides insights across latest advancements for chronic pain management and COVID-19 testing.

The TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Key Topics Covered:

For more information about this report visit https://www.researchandmarkets.com/r/v6l8dq

Read the rest here:

Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies, 2020 Report - Focus on Latest Advancements for Chronic Pain...

NHMRC awards Griffith University $4.5 million in research funding – Griffith News

Key Griffith University research projects have received $4.5 million in funding from the National Health and Medical Research Council.

Announced on December 15 by the Federal Minister for Health, The Honorable Greg Hunt MP, the seven Ideas Grants projects will contribute to vital health and medical research.

Deputy Vice Chancellor (Research) Professor Mario Pinto said the funding highlights the extraordinary work conducted by the Universitys researchers in addressing major societal health challenges.

These projects have the potential to make a significant difference to peoples health and wellbeing. I extend my congratulations and appreciation to all staff who have contributed to these efforts.

More than half the funding for Griffith University was awarded to projects within theInstitute for Glycomics, withfour research projects securing $2.56 million to explore a super vaccine that tackles bothinfluenza virus andGroup A Streptococcus bacteria and other vaccine development projects that tackle other clinically important bacterial infections.

Institute Director Professor Mark von Itzstein AO said the awards cemented the Institutes reputation as a leading biomedical research institute.

Our institute is focussed on translational research outcomes that diagnose, prevent and treat diseases of global impact. These grants will significantly assist our researchers to deliver on our mission to achieve a disease-free world.

NHMRC Ideas

Dr Mehfuz Zaman, Professor Mark von Itzstein and Professor Michael Good (Institute for Glycomics) awarded $707, 717 for the project Vaccine to prevent Influenza Virus and Bacterial superinfection (Associate Professor Victor Huber, University of South Dakota).

Associate Professor Kate Seib, Professor Michael Jennings and Dr Arun Everest-Dass (Institute for Glycomics) awarded $826,490 for the project Gonococcal vaccine development guided by a cross-protective meningococcal vaccine (Dr Caroline Thng, Gold Coast Health).

Dr Freda Jen, Associate Professor Kate Seib, Professor Michael Jennings and Dr Milton Kiefel (Institute for Glycomics) awarded $526,949.6 for the project Targeting a bacterial glycol-Achilles heel to make new vaccines for Haemophilus influenzae and Neisseria gonorrhoeae.

Professor Michael Jennings, Associate Professor Thomas Haselhorst, Dr Lucy Shewell, Dr Christopher Day (Institute for Glycomics) awarded $608,425 for the project Structure and biophysical analysis aided design of novel toxoid vaccines for a major class of bacterial toxins (Prof James Paton, The University of Adelaide, Prof Mark Walker, The University of Queensland and Prof Victor Torres, New York University).

Dr David Lloyd, Dr Claudio Pizzolato, Dr David Saxby and Dr Laura Diamond (Menzies Health Institute Queensland) awarded $860, 231 for the project Osteoarthritis compass: Predicting personalized disease onset and progression with future capacity for clinical use (Dr Michelle Hall, Assoc Prof Adam Bryant University of Melbourne, Prof David Hunter, University of Sydney; Prof Juha Toyras, Dr Shekhar Chandra, Assoc Prof Craig Engstrom The University of Queensland; Dr Jurgen Fripp, CSIRO Australian e-Health Research Centre; Prof Rami Korhonen, University of Eastern Finland).

Professor Heidi Zeeman, Dr David Painter and Professor Elizabeth Kendall (Menzies Health Institute Queensland) awarded $513, 483 for the project Dimensional Attention Modelling for Neglect Detection (DIAMOND): A novel application for brain injury (Prof Julie Bernhardt, Florey Institute of Neuroscience and Mental Health).

Associate Professor Hang Ta (Queensland Micro and Nanotechnology Centre/GRIDD) awarded $523, 342 for the project Developing smart nanomedicine to enable advanced diagnosis and stimuli-responsive treatment for atherosclerosis and thrombosis (Dr Nghia Truong Phuoc, Monash University; Dr Gary Cowin, Dr Nyoman Kurniawan, Prof Zhiping Xu, The University of Queensland and Prof Karlheinz Peter, Baker Heart and Diabetes Institute).

Griffith researchers involved in research led by other institutions

NHMRC Ideas

Prof Randipsingh Bindra, Dr Mo Chen, Assoc Prof James St John, Assoc Prof Jenny Ekberg, Dr Brent McMonagle (Griffith Health) are part of a team led by Assoc Prof Jeremy Crook (University of Wollongong) awarded $805,064.45 for the project titled A wireless electric nerve-guide for peripheral nerve repair (Dr Eva Tomaskovic-Crook, University of Wollongong).

Assoc Prof Joshua Byrnes (MHIQ, Health) is part of a team led by Assoc Prof Maree Toombs (The University of Queensland) awarded $1,279,602.45 for the project titled Advancing equitable and non-discriminatory access to health services for First Nations peoples: A multidisciplinary Queensland Human Rights Act case study (Dr Shivashankar Hiriyur Nagaraj, Queensland University of Technology; Jodie Luck, Mr DanielWilliamson, Queensland Health; Mr Jed Fraser, Queensland Aboriginal and Islander Health Council; Prof Anthony Smith, Dr Claire Brolan Dr Caitlin Curtis, Dr Sandra Creamer, Prof Wendy Hoy, Dr Amelia Radke (The University of Queensland), Dr Kelly Dingli (Queensland Aboriginal and Islander Health Council); Mr Gregory Pratt (The Council of the Queensland Institute of Medical Research)

ARC Linkage 2020 Round 1

Dr Pooja Sawrikar (School of Human Services and Social Work) is part of a Western Sydney University project led by Assoc Prof Rebekah Grace awarded $387,107 for the project Upholding the right to cultural connection for children in care.

Link:

NHMRC awards Griffith University $4.5 million in research funding - Griffith News

Clene Nanomedicine Presents Blinded Interim Results from RESCUE-ALS Phase 2 Study at the 31st International Symposium on ALS/MNDResults provide…

SALT LAKE CITY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of blinded interim results from the Phase 2 RESCUE-ALS clinical trial investigating the effects of its lead clinical candidate, CNM-Au8, for the treatment of amyotrophic lateral sclerosis (ALS). CNM-Au8 is an aqueous suspension of clean-surfaced, faceted gold nanocrystals with catalytic activity that has been shown to enhance the metabolic energetic capacity of motor neurons while simultaneouslyreducing oxidative stress.

As of the data cutoff (October 27, 2020), the trial was fully enrolled with a preliminary blinded assessment of the studys primary endpoint, the motor neuron number index-4 [MUNIX(4)] score, showing that more than 40% of enrolled patients with completed week 12 data experienced improvements in motor neuron function assessed by MUNIX. When compared to baseline values, the average MUNIX(4) score of the overall trial population (including both active CNM-Au8 and placebo) experienced an absolute increase in mean MUNIX(4) values. This increase exceeded the expectations of the statistical modeling on which the study was based, which predicted a linear decline in average MUNIX(4) score from study onset (Neuwirth et al. JNNP 2015). These data, while blinded, suggest that CNM-Au8 may have neuro-reparative potential in ALS patients. Clene expects to report the complete, unblinded results from the RESCUE-ALS study in 2H 2021.

Although blinded to treatment assignment, these data are encouraging. We believe Clenes breakthrough approach with the application of physics to biology via direct electron interactions within cellular systems at the nano-scale may hold the potential to revolutionize the treatment of neurodegenerative diseases such as ALS and other motor neuron diseases, said Robert Glanzman, MD, FAAN, Chief Medical Officer of Clene.

Rob Etherington, President and CEO of Clene added, This blinded interim analysis suggests that CNM-Au8 is working mechanistically to address a foundational challenge common to many neurodegenerative diseases, namely that stressed or failing neurons need additional energy for their survival, repair, and improved function. Emerging MUNIX data potentially indicate preservation of motor units, which is promising. We eagerly anticipate final results and are encouraged that these blinded interim results may provide hope for ALS patients and their families as they search for new therapies to treat this devastating disease.

The presentation (CLT-23) titled, RESCUE-ALS Trial, A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CNM-Au8 to Slow Disease Progression in Amyotrophic Lateral Sclerosis Patients: Design and Interim Blinded Results, is available as a live e-Poster on December 10th at 12:10 12:50 pm EST at the Virtual 31st International Symposium on ALS/MND, held online (https://symposium.mndassociation.org/virtual-2020/).

About RESCUE-ALSRESCUE-ALS is a Phase 2 multi-center, randomized, double-blind, parallel group, placebo-controlled study examining the efficacy, safety, pharmacokinetics and pharmacodynamics of CNM-Au8 in participants who are newly symptomatic with ALS (within 24-months of screening or 12-months from diagnosis). Enrolled subjects will be randomized 1:1 to receive either active treatment with CNM-Au8 (30 mg) or placebo in addition to their current standard of care. Participants will receive their randomized treatment over 36 consecutive weeks during the treatment period. The objective of this study is to assess the impact of improving neuronal bioenergetics, reducing reactive oxygen species and promoting protein homeostasis with CNM-Au8 to slow disease progression in patients with ALS. In the trial, efficacy is assessed as the average change in motor neuron unit number index (MUNIX) estimated by electromyography for the abductor digiti minimi (ADM), abductor pollicis brevis (APB), biceps brachii (BB), and tibialis anterior (TA) (muscles of the hand, arm, and leg). The trial was fully enrolled with 44 participants as of the reported 27-October-2020 data cut. Baseline characteristics include [mean (SD)], MUNIX(4) score: 93.7 (45.8); FVC % predicted: 80.8 (16.3); ALSFRS-R: 38.6 (6.1); ALSSQOL-20: 3.3 (1.3), mean time from diagnosis: 4.7 (4.6) months; riluzole background treatment, 92%.

About CNM-Au8CNM-Au8 is a concentrated, aqueous suspension of clean-surfaced faceted gold nanocrystals that act catalytically to support important intracellular biological reactions. CNM-Au8 consists solely of pure gold nanoparticles, composed of clean-surfaced, faceted, geometrical crystals held in suspension in sodium bicarbonate buffered, pharmaceutical grade water. CNM-Au8 has demonstrated safety in Phase 1 studies in healthy volunteers and has shown both remyelination and neuroprotective effects in multiple preclinical (animal) models. Preclinical data, both published in peer-reviewed journals and presented at scientific congresses, demonstrate that treatment of neuronal cultures with CNM-Au8 improves survival of neurons, protects neurite networks, decreases intracellular levels of reactive oxygen species and improves mitochondrial capacity in response to cellular stresses induced by multiple disease-relevant neurotoxins. Oral treatment with CNM-Au8 improved functional behaviors in rodent models of ALS, multiple sclerosis, and Parkinsons disease versus vehicle (placebo). CNM-Au8 is currently being tested in a Phase 2 clinical study for the treatment of chronic optic neuropathy in patients with MS in addition to Phase 2 and Phase 3 clinical studies for disease progression in patients with ALS.

About ALSALS is a universally fatal neurodegenerative disorder that results in loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. ALS, also known as Lou Gehrig's disease, leads to the death of the neurons controlling voluntary muscles resulting in weakness, muscle atrophy, and progressive paralysis. ALS affects more than 15,000 patients in the United States and is the most prevalent adult-onset progressive motor neuron disease.

About CleneClene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland. For more information, please visit http://www.clene.com.

Forward-Looking StatementsThis press release contains, and certain oral statements made by representatives of Tottenham, Clene, and their respective affiliates, from time to time may contain, "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Tottenham's and Clene's actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "might" and "continues," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Tottenham's and Clene's expectations with respect to future performance and anticipated financial impacts of the business combination, the satisfaction of the closing conditions to the business combination and the timing of the completion of the business combination. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside the control of Tottenham or Clene and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement relating to the proposed business combination; (2) the outcome of any legal proceedings that may be instituted against Tottenham or Clene following the announcement of the Merger Agreement and the transactions contemplated therein; (3) the inability to complete the business combination, including due to failure to obtain approval of the shareholders of Tottenham or other conditions to closing in the Merger Agreement; (4) delays in obtaining or the inability to obtain necessary regulatory approvals (including approval from regulators, as applicable) required to complete the transactions contemplated by the Merger Agreement; (5) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement or could otherwise cause the transaction to fail to close; (6) the inability to obtain or maintain the listing of the post-acquisition company's ordinary shares on NASDAQ following the business combination; (7) the risk that the business combination disrupts current plans and operations as a result of the announcement and consummation of the business combination; (8) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably and retain its key employees; (9) costs related to the business combination; (10) changes in applicable laws or regulations; (11) the possibility that Clene or the combined company may be adversely affected by other economic, business, and/or competitive factors; and (12) other risks and uncertainties to be identified in the Form S-4 filed by Chelsea Worldwide (when available) relating to the business combination, including those under "Risk Factors" therein, and in other filings with the Securities and Exchange Commission (SEC) made by Tottenham and Clene. Tottenham and Clene caution that the foregoing list of factors is neither exclusive nor exhaustive. Tottenham and Clene caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Neither Tottenham or Clene undertakes or accepts any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law. The information contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.

Media ContactAndrew MielachLifeSci Communications(646) 876-5868amielach@lifescicomms.com

Investor ContactBruce MackleLifeSci Advisors, LLC(929) 469-3859bmackle@lifesciadvisors.com

Continue reading here:

Clene Nanomedicine Presents Blinded Interim Results from RESCUE-ALS Phase 2 Study at the 31st International Symposium on ALS/MNDResults provide...

$700 Million Worth of Synthetic Bitcoin Is Circulating on the Ethereum Blockchain – Bitcoin News

According to onchain data, theres now 69,836 synthetic bitcoin tokens (over $700 million) circulating on the Ethereum blockchain. Out of the six synthetic bitcoin token projects, wrapped bitcoin (WBTC) commands the largest number of coins with over 63% and 44,622 WBTC.

Synthetic bitcoin (BTC) has grown massively in recent weeks and since news.Bitcoin.coms last report on the subject, there was 38,021 BTC circulating on the Ethereum chain.

Since then, that metric has jumped more than 83% as theres now 69,836 synthetic bitcoin tokens in the wild on September 7, 2020. Dune Analytics shows there are seven synthetic BTC projects but tBTC has zero coins minted, while the other six projects have between 45 BTC to over 40,000.

The top project minting the most synthetic BTC is the Wrapped Bitcoin (WBTC) protocol which commands roughly 44,622 BTC to-date or 63%. The Ren Protocols renBTC has over 23% of the aggregate total of synthetic BTC with 16,268 renBTC in circulation today.

The token hBTC has 4,810 and sBTC has a total of 2,918 at the time of publication. The two projects with the least amount of synthetic BTC is imBTC (1,173) and pBTC (45).

WBTC has gained a lot of traction, and on Monday reports detail that the organization Alameda Research obtained 70% of the WBTC minted in August. Alameda was cofounded by the FTX CEO Sam Bankman-Fried.

A great percentage of synthetic bitcoin is circulating among holders while the rest is used on platforms such as Compound, Balancer, Aave, and Uniswap.

Synthetic bitcoin trades take place on a few centralized exchanges like FTX and Binance has revealed listing WBTC this week. On decentralized exchange (dex) platforms, Synthetic bitcoin trades are happening on 0x, Bancor, Synthetix, Balance, Curve, and Uniswap.

Despite the massive growth and popularity, Ethereum cofounder Vitalik Buterin detailed that he has concerns about synthetic bitcoin projects.

I continue to be worried about the fact that these wrapped BTC bridges are trusted, Buterin wrote on August 16. I hope they can all *at least* move to a decently sized multi-sig, the developer added.

Following Buterins statements, the community discussed a research paper by the Wanchain project which claimed the Ren Protocol kept all the collateralized bitcoin in one address.

Paradoxically, we found that the Bitcoin address provided by renBTC that users transfer their real BTC to for locking has not changed since the first day it went online, the Wanchain report wrote.

Despite the trust issues, with 69,836 synthetic bitcoin tokens on the Ethereum blockchain, the ETH network continues to solidify itself as BTCs most dominant offchain solution.

What do you think about the $700 million worth of BTC circulating on the ETH chain in synthetic form? Let us know in the comments below.

Image Credits: Shutterstock, Pixabay, Wiki Commons, Dune Analytics,

Disclaimer: This article is for informational purposes only. It is not a direct offer or solicitation of an offer to buy or sell, or a recommendation or endorsement of any products, services, or companies. Bitcoin.com does not provide investment, tax, legal, or accounting advice. Neither the company nor the author is responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

Read the original here:

$700 Million Worth of Synthetic Bitcoin Is Circulating on the Ethereum Blockchain - Bitcoin News

Exclusive mining could have negative implications for the Blockchain industry, say experts – Cointelegraph

Dr. Elias Strehle of the Blockchain Research Lab and Lennar Ante of the University of Hamburg recently warned that blockchain nodes engaging in exclusive mining have no incentive to forward new transactions to their peers.

They speculated that crypto miners may instead be incentivized to keep transactions confidential in the hope of being the only one who can earn the associated transaction fees.

Exclusive mining, which is a type of collusion between a transaction initiator and a single miner or pool, uses private channels to confirm transactions rather than broadcasting them on the public blockchain. It is only after they are recorded in a block that public blockchain that users become aware of such transactions.

The authors alleged that, since transaction costs represent regular income for miners, significantly increased transaction costs could be used to launder money by colluding with a miner.

As a result, criminals may see smaller blockchain networks as more suitable vehicles for money laundering or tax evasion via exclusive mining, the researchers noted.

Dr. Strehle and Ante identified two other possible motivations for engaging in exclusive mining: reducing transaction cost volatility and hiding unconfirmed transactions from the network to prevent frontrunning.

In June, Cointelegraph reported on a number of mysterious transactions that have stumped the wider community. Some suggest they could be examples of money laundering, or revenge from a disgruntled exchange employee.

Read more from the original source:

Exclusive mining could have negative implications for the Blockchain industry, say experts - Cointelegraph

Reimagining blockchain for healthcare solutions with the MAXathon – Health Europa

Blockchain technology company Maxonrow is hosting its first ever hackathon to help reimagine blockchain for applications in healthcare in response to the global challenges posed by the COVID-19 pandemic.

The MAXathon challenges are based on the Maxonrow SDK script, which the company used to build MedsLOCK. Created in tandem with Avantas Tech Accelerator, MedsLOCK is a blockchain-based control and communication ecosystem that provides real-time insights during pandemics.

During the COVID-19 outbreak, data is crucial to making informed decisions. At the same time, citizens are concerned about any incursion to privacy resulting from data collection initiatives.The MedsLOCK platform provides a single source of reliable, verifiable pandemic analytics to government agencies, health officials, and other stakeholders, and the core objective is to make COVID-19 data collection and exchange between stakeholders automated, transparent, and trusted with the help of distributed ledger technology.

Muhammad Salman Anjum, Avantas Managing Director, said: Privacy is a key issue during the current and future pandemics, and as such, blockchain platforms ensure that information is shared without compromising privacy. With MedsLOCK, we make sure we add trust to the data flow.

Participants in the MAXathon hackathon will have a chance to win a share of a 15,000 prize pool by building solutions for any of the five challenge categories.

The challenges categories are:

Physical Distancing Distancing measures are one of the most impactful ways to contain the spread of COVID-19. How can we use analytics in smarter solutions to help governments implement social or physical distancing measures?

Credential and Certificate Issuance Governments need a way of easily verifying if a patient has had COVID-19 and is virus-free. Help us build a solution that can help governments quickly retrieve verifiable data.

Welfare Businesses and citizens have become reliant on governments for welfare due to the restrictions imposed by the pandemic. Can we lower transaction costs by removing intermediaries and increasing transparency to welfare beneficiaries?

Virtualising the New Normal Are there any creative ways that blockchain can be used to navigate the need for physical distancing, creating new virtual paths to connect with one another?

UI/UX There are many data representations of the pandemic. How can we present a holistic, multi-dimensional dashboard with unique features?

Maxonrow has assembled a stellar team of judges and mentors for MAXathon, including Holger Schmidt, partner at PwCs strategy division, Nisa Amoils of VC firm Grasshopper Capital, along with representatives from Audi, Dash.org, and members of Maxonrow and Avantas Techs senior leadership.

There will also be 16 mentors working with participating teams, comprised of members of Maxonrows technical teams and leaders within the blockchain space.

The latter includes Amber Urquhart, Head of Business Development at quant trading firm TDX Strategies, Gabriel Dymowski, CEO at Doxychain, and a laureate of Forbes 25 under 25. Also participating in the mentorship team are Massimo Buoni, a UN global technology expert, and Steven Boylan, co-founder and CEO of Trt:Labs, a specialist digital transformation consultancy.

More:

Reimagining blockchain for healthcare solutions with the MAXathon - Health Europa

All fintech companies will use blockchain within 10 years: Aussie government report – Cointelegraph

The Australian governments Senate Select Committee on Financial Technology and Regulatory Technology has released a draft report citing blockchain technology more than 50 times.

The report is in response to Australias first recession in 30 years as a result of COVID-19, which was confirmed in the June quarters negative growth announced on September 2.

The document makes numerous recommendations about how the nation can embrace technology and become globally competitive said committee head Senator Andrew Bragg. He added:

There are dozens of references to blockchain and distributed ledger technology and the report cites submissions to the committee that blockchain's potential is estimated at $175 billion annually within five years and $3 trillion by 2030. It quoted Piper Alderman partner Michael Bacina as saying blockchains use cases would grow exponentially across the financial and regulatory sectors:

The tax treatment of Initial Coin Offerings (ICOs) was addressed specifically with the recommendation that the regulatory framework around ICOs be developed to encourage blockchain development rather than inhibit it.

Power Ledgers co-founder and Executive Chairman Dr Jemma Green highlighted that more than $26 billion had been raised through ICOs, however Australia has captured less than one percent of this value. She explained that by implementing new tax regulations the country could capitalise on the opportunity, to capture a bigger piece of that $26 billion pie which would result in employment for employ tens of thousands of people.

Other use-cases for the technology cited include blockchain as a reporting and management tool for property data and investments, and within the credentialing sector.

The technology will also play an integral part in Australia's farming success through agricultural advancements, a sector set to grow to $100 billion by 2030 according to the National Farmers Federation. Senator Bragg said innovative technology is the only future for the farming sector.

The Committee will submit the final report in April 2021.

See more here:

All fintech companies will use blockchain within 10 years: Aussie government report - Cointelegraph

‘Decentralized Reddit’ enables users to secure Twitter on the blockchain – Cointelegraph

Reddit-inspired social aggregation platform Discussions.app announced its expansion to the Telos network on Sept. 3.

The first project to come out of the new collaboration will be a decentralized identity system, allowing users to record their accounts and contacts from Twitter and other social networks to the blockchain in the event of a block or ban.

In the social-media age, users spend years growing networks and followers on various platforms, although this work can be destroyed by the sometimes arbitrary-seeming decisions of the networks.

Discussions.app addresses this by allowing users to migrate across platforms without losing their valuable identities and connections. Telos chief architect Douglas Horn explained the problem:

It seems that every few days I see another unique voice de-platformed and the connections they invested years building pulled out from under them like a cheap rug especially in the crypto community. Discussions.app empowers individuals to secure their own social networks immune to the whims of Facebook, YouTube and Twitter.

As Cointelegraph reported, YouTube has arbitrarily banned (and then reinstated) a number of crypto-related channels over the past few months. In May, the platform even pulled the plug on our special livestream of the halving event.

In addition to digital identity management, Telos will provide Discussions.app with options for advanced governance and Ethereum Virtual Machines which can run Ethereum-compatible smart contracts with zero transaction fees.

Go here to read the rest:

'Decentralized Reddit' enables users to secure Twitter on the blockchain - Cointelegraph

Former Georgian PM: Blockchain is the steam engine of Industry 4.0 – Cointelegraph

Located at the intersection between Europe and Asia, Georgia is a small country with a big mission to drive blockchain adoption and education. In February 2017, the government of Georgia made a bold move by signing an agreement to use the Bitcoin blockchain to record land titles, making it the first national government to use blockchain for authenticating state operations.

Georgias innovation didnt stop there, rather continuing to grow as the country became a powerhouse for mining crypto. Then, in June 2019, the government of Georgia signed a memorandum of understanding with blockchain technology firm Input Output Hong Kong, or IOHK, to advance blockchain projects across government sectors, with a large focus on education.

Many of these innovations took place when Mamuka Bakhtadze served as the countrys prime minister, between June 2018 through September 2019. Cointelegraph had the pleasure of sitting down with Bakhtadze to learn more about his goals to drive blockchain innovation and education.

Rachel Wolfson: How did you start implementing blockchain and digital currencies into policy when you were Prime Minister of Georgia?

Mamuka Bakhtadze: This actually started before I became prime minister of Georgia. Georgia is the first country that introduced blockchain technology in public services. That happened a few years ago, when we partnered with the blockchain company Bitfury.

Our Ministry of Justice implemented Bitfurys blockchain to register and verify property transactions. This was the first time not only for Georgia, but for any state to implement blockchain in the public services sector.

RW: You recently spoke at the virtual Davos event this year about taking blockchain further; what can the future hold?

MB: Georgia is a very good example of the limitless opportunities associated with blockchain, especially within the public services sector. Currently, we are implementing a very important project in the education sector together with IOHK and Charles Hoskinson, who is a very good friend of Georgia. Together with the Ministry of Justice and Minister for Education, we are implementing the credentials verification project. The team is using a Cardano-backed blockchain for this.

When you want to make a transformation for your country, its very important to have a national idea that will consolidate the energy and effort required for it. In our opinion, this was education. In 2019, we initiated an education reform, and now, according to our legislation, it is mandatory for any government to invest 6% of GDP in education, which is around 25% of our budget.

So education is really a big element for Georgia. With this reform, we hope that we will be able to position Georgia as a hub for innovation, and blockchain plays a large role in this. The project that we are doing now with the Input Output team is very important from that perspective.

RW: Is Cardano and IOHK also setting up an education center in Georgia, where theyre teaching students about blockchain and then providing career opportunities?

MB: This is part of phase two of the plan. The first phase, as I have mentioned, is to finalize this project for credentials verification. The next phase will focus on the skill-building process for Georgians who would like to become part of this great initiative.

RW: Is the Georgian government also looking to implement blockchain solutions to revive tourism and travel that may have been impacted by COVID-19?

MB: Tourism is a very important industry for Georgia. Our population is less than 4 million people, and last year, we hosted more than 9 million visitors. So, tourism is really a very important industry for both the country and our economy.

I think blockchain can provide some very interesting solutions to this problem. Many countries are now trying to get data showing whether people have been tested for COVID-19. They also want information to show whether people have been living in so-called high-risk zones. At the same time, this is very sensitive data. Therefore, the security and safety measures of how to use this data is very important.

Blockchain can provide some interesting solutions for countries like Georgia who are so dependent on tourism. I know that there are some Asian countries that are working very intensively on these solutions. Georgia should also determine which technologies we will have to use to increase our visitors again. I think that blockchain would be the right answer to this question.

RW: What are your thoughts on Bitcoin and cryptocurrency in general, and how is this being applied in Georgia?

MB: Im a strong advocate for digital currencies and I have many strong arguments for being so supportive. Its a fact that we are living in the era of the Fourth Industrial Revolution. Digital currencies are an inevitable part of this era. At the same time, the lessons learned from the previous industrial revolutions are very interesting.

However, for countries like Georgia, the use of digital currencies an organic part of the fourth industrial revolution should become part of the transformation for both nations and their economies. Moreover, what we are learning now from the COVID-19 pandemic shows that the global economy needs digital currencies and cryptocurrency, which will make transactions safer and more efficient. Therefore, I think that its an inevitable process.

Of course, there are a lot of barriers, and I really do hope to see more of an open-minded approach from governments and regulators when it comes to digital currencies. But the bottom line is that all of us should understand that this move is inevitable. The countries who will be more supportive of digital currencies and cryptocurrencies will have a very significant competitive advantage in the 21st century. Georgia cannot afford to miss this opportunity.

RW: So would you say Georgia is crypto-friendly? Are digital assets going to be adopted in Georgia earlier than other places in the world?

MB: Im optimistic about this, and just to finalize the comparison I made with the first industrial revolution, I think another big part of this will be blockchain adoption. Blockchain will have the same impact as the steam engine had during the first industrial revolution. The first industrial revolution was powered by the steam engine and the fourth industrial revolution will be powered by blockchain. Thats really a game changer.

When it comes to regulations, politicians everywhere in the world and in Georgia should be more open-minded. Once again, the pandemic has shown us why. The global economy needs digital currencies now.

There are also a number of other initiatives. Of course, I would like to see Georgia as a frontrunner when it comes to blockchain and digital currencies.

Originally posted here:

Former Georgian PM: Blockchain is the steam engine of Industry 4.0 - Cointelegraph

How will decentralized blockchain technology evolve in the future? – Gary Skentelbery

So far, decentralized blockchain is best known as the technology that underpins Bitcoin and Ethereum. These public blockchain networks dominate the scene, both in terms of developer activity and cryptocurrencies traded.

Thats unsurprising considering the innovation both have enabled. A decade ago, Bitcoin provided a way for us to exchange value digitally and in a peer to peer manner with anyone else in the world. Roughly five years later, Ethereum enabled us to build sophisticated services around these value exchanges in the form of smart contract-enabled decentralized applications.

All of this innovation is understood by most people to revolve around decentralization. But what actually is decentralized blockchain?

This is an important question to be clear about before we look ahead to what the future holds and it is one that L3COS, a regulated blockchain-based operating system I recently discovered, does a good job of explaining.

It describes decentralized blockchain, as proposed by the creator of the Ethereum blockchain, Vitalik Buterin, as having three parts political decentralization, architectural decentralization and logical centralization.

Political decentralization means there is no regulating central authority, as is the case with Bitcoin. Architectural decentralization relates to infrastructure, with a network of distributed computers keeping the blockchain running together, so there is no single point of failure.

Logical centralization relates to the commonly agreed state of data, with all computers in a decentralized network sharing a single database.

As mentioned, these characteristics have been established norms for decentralized networks for many years now. However, as blockchain increases in significance with a wider variety of entities using the technology, the question of whether this will always be the case is an interesting thread thats worth pursuing.

Its worth stating that Bitcoin and Ethereum seem very unlikely to disappear entirely. Although they have not been adapted en masse, there have been signs in recent months that more and more of the traditional finance world is increasing its exposure to these key digital assets.

However, there is another important dynamic emerging in the world of blockchain that could have an important impact on the evolution of decentralized blockchain. Governments around the world are investigating the idea of issuing Central Bank Digital Currencies and using blockchain as the technology that underpins them. If they do so, they are unlikely to choose a blockchain that is politically decentralized in the way that Bitcoin and Ethereum are. This is noteworthy in relation to L3COS, which describes itself in the following terms:

Unlike most blockchains, L3COS is politically centralized. The operating system is designed to be regulated by the government.

It goes on to say that the system is based on three user levels, governments and members, businesses and their representatives, and society and individuals. Each level has its sublevels and permissions can be regulated on a personal basis, with the government ensuring every participant complies with these regulations.

The L3COS blockchain is architecturally decentralized but it is politically centralized. It claims to provide all the benefits of decentralization in terms of security, scalability, attack resistance and direct transactions between participants. However it also claims that regulation by government means the power of the technology will finally be recognised by businesses and individuals.

It seems clear that, now blockchain is really moving into the mainstream as a result of more and more governments and businesses using it, the technology will change from what we have today. In truth, the established decentralised networks may be extremely popular within the blockchain community but they are still just a tiny slice of the digital world.

These networks are unlikely to disappear as so many within the community have invested so much in them. But for new entrants who arent already affiliated with a particular network or community, they will be looking for the best solution for the needs. Who knows what this will mean for the future but theres no doubt government use of blockchain will be an increasingly important force and could have a dramatic effect on the evolution of decentralized blockchain.

See the original post:

How will decentralized blockchain technology evolve in the future? - Gary Skentelbery

Starbucks’ Deployment of a Blockchain Network May Show Restaurants the Way to Future Revenue Growth | – Restaurant Technology News

Soon it will no longer be a matter of just listing all your niche providers but being able to prove their legitimacy. This is not just for coffee, either. Think of every ingredient or item on display whose price could be enhanced through more granular traceability.By Larry Mogelonsky, Principal of Hotel Mogel Consulting Limited - 9.5.2020

Amidst all the headlines about COVID-19, you may have missed the coverage of what is potentially a gamechanger in the foodservice and retail industries. First announced over a year ago, Starbucks is now readying to deploy a blockchain network for end-to-end coffee bean traceability and greater product transparency, and this will soon influence what motivates customers to buy at your restaurant, sundry or store.

I love Starbucks. Not only are its products consistently great but, as a former advertising exec, the companys branding and marketing are perennially some of the best in the world. While undoubtedly you can find better coffee at independent cafs throughout the Mediterranean and Middle East, as a global franchisor Starbucks has revolutionized the way the world views and values coffee.

A while back, I wrote an article entitled, Fast Food Restaurants are Where Food Trends Go to Die, describing how, by the time you see a food trend being advertised by a major chain, its a mature concept and can no longer generate buzz for your own business. The underlying lesson here was to differentiate your product by not directly copying what dining patrons could find everywhere else. Starbucks, however, may be the exception to this principle in that it is the gold standard for premium coffee service and often the trendsetter for the industry rather than a laggard.

In essence, if you cant do better than Starbucks then why even bother? Now after its latest partnership with Microsoft to build a verifiable coffee production blockchain, Starbucks is raising the bar again where it goes, the competition will be forced to follow or inevitably lose market share.

As a start, blockchain is far more than just swanky cryptocurrencies like Bitcoin or Ethereum, and it would certainly help for you to cultivate a basic understanding of how the technology works. You wont need to become versed in distributed systems architecture, but you should know how a decentralized hyperledger with algorithmically linked or hashed and timestamped transactions can be used to authenticate a products origins. Plenty of resources exist online for you to peruse.

Now lets look at how the application of blockchain will evolve our current practices. Over a decade ago, hotels and restaurants started to embrace the concept of authentically local as a means of product differentiation and commanding higher prices. For eateries specifically, the locavore movement and reducing food miles became a way to simultaneously improve ingredient quality, support the region, take a stance against environmental degradation and justify upcharging customers to cover the increased costs. But how do you truly know if something is local besides taking a restaurant at its word?

Just as Burger King or Subway putting sriracha on the menu signaled the omnipresence and inert familiarity with this once-buzzy, Southeast Asian hot sauce, local has also lost much of its luster simply because everyone else is doing it. When you say that all your ingredients are locally sourced, it still adds value to the experience, but this messaging can no longer be assumed to be a primary motivator for customers to choose you over the competition. And at the luxury end, local in all things is now a firm expectation rather than a value-add.

Traceability, as powered by blockchain, is a strong contender to be the local for the new decade because it deepens the trust that guests will have with your products and it allows you, the purveyor, to source from niche producers around the world while also limiting the unethical interloping of middlemen. When it comes to marketing coffee, single origin has been a powerful trend for helping brand luxury products over the past five to ten years as people can choose between beans produced on an individual farm or small geographic territory in, say, Nicaragua versus from a Colombian finca, enriching the customer experience in the process. Blockchain adds an extra layer of security and authenticity to this model in that the beans are now exactly where they say they are from.

While setting up your own blockchain is likely an insurmountable task for any enterprise not approximating the size of Starbucks, perhaps in the near future there will be a consortium blockchain that you can subscribe to. Piggybacking on these networks may also entail many other operations besides supply chain management, notably facilitating secure contactless payments without the worry of chargeback disputes. In the meanwhile, whats important is that you grasp how this latest news will come to heighten guests demand for digital product transparency.

Soon it will no longer be a matter of just listing all your niche providers but being able to prove their legitimacy. This is not just for coffee, either. Think of every ingredient or item on display whose price could be enhanced through more granular traceability.

Do you believe that showing the exact cow pasture where a steak came from will allow you to charge more for that piece of meat? How about chocolate where cocoa is mostly produced in West Africa and yet those countries have largely failed to develop a homegrown direct-to-consumer industry because of too much exploitation by nefarious wholesalers? What if, instead of trumpeting your Belgian or Swiss chocolates, you vended products from an Ivory Coast startup that used blockchain to verify that its beans were wholly fair-trade or responsibly farmed.

While blockchain is a lofty goal these days for just about any hospitality organization, there are other old school ways you can deploy in the meantime to attain better product transparency, and you should consider them to help drive revenues for the decade ahead.

The worlds most published writer in hospitality,LarryMogelonsky is the principal of Hotel Mogel Consulting Limited, a Toronto-based consulting practice. His experience encompasses hotel properties around the world, both branded and independent, and ranging from luxury and boutique to select-service.Larryis also on several boards for companies focused on hotel technology. His work includes four books Are You an Ostrich or a Llama? (2012), Llamas Rule (2013), Hotel Llama (2015), The Llama is Inn (2017),The Hotel Mogel (2018)and More Hotel Mogel (2020). You can reachLarryatlarry@hotelmogel.comto discuss hotel business challenges or to book speaking engagements.

This article may not be reproduced without the expressed permission of the author.

Are you an industry thought leader with a point of view on restaurant technology that you would like to share with our readers? If so, we invite you toreview our editorial guidelines and submit your articlefor publishing consideration.

See original here:

Starbucks' Deployment of a Blockchain Network May Show Restaurants the Way to Future Revenue Growth | - Restaurant Technology News